Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA

Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA. Smith, J.; Nazare, J.-A.; Borel, A.-L.; Aschner, P.; Barter, P. J.; Van Gaal, L.; Matsuzawa, Y.; Kadowaki, T.; Ross, R.; Brulle-Wohlhueter, C.; Alméras, N.; Haffner, S. M.; Balkau, B.; Després, J.-P.. Diabetes, Obesity & Metabolism. 2013; 15: p.629-641. doi:10.1111/dom.12075
Article